U.S. Implantable Medical Devices Market (Product Type: Orthopedic Implants [Reconstructive Joint Replacement and Spinal Implants], Cardiovascular Implants, Dental Implants, Intraocular Lens, Breast Implants, and Other Implants)- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the U.S. Implantable Medical Devices market size is expected to hit around USD 51.9 billion by 2030 from valued at USD 36.03 billion in 2021 and growing at a CAGR of 9.50% from 2022 to 2030.increase in incidence of organ failures, owing to chronic disorders and accidents, boosts the growth of the implantable medical devices market

The per capita income of the U.S. population is high. Moreover, availability of better and advanced healthcare facilities has resulted in people spending more on healthcare.

The population of the U.S. is more conscious about their health and is inclined toward spending on the best care possible. This has resulted in patients preferring technically evolved implantation procedures against conventional pharmacological therapies.

Nanotechnology is the future of implantable devices. Increase in sophistication will improve the efficacy of the devices.

Manufacturers of implantable devices are working toward developing technologically advanced products. If they are successful in early launch of the products, they will be highly successful in tapping a large market share in their domain and become market leaders.

Report Scope of the U.S. Implantable Medical Devices Market

Minimally-invasive Implantable Medical Devices Help Increase Patient Outcomes

Patients prefer minimally invasive surgery, as it includes short recovery time, less post-surgery complications, and low side effects. Therefore, minimally-invasive nature of interventional cardiology acts as a driver for the market. The minimally-invasive nature of these surgery procedures play an instrumental role in the decision making of patients to undergo interventional cardiac treatments.

Rise in demand for minimally invasive procedures, high purchasing power of the population, aging population, and high obesity rates are anticipated to steer the growth of the U.S. implantable medical devices market during the forecast period. Well-established healthcare infrastructure, availability of reimbursements, and introduction of the Affordable Care Act in the U.S. are expected to drive the market.

Patients with Comorbidities Key Focus of Device Manufacturers During COVID-19 Pandemic

Companies in the U.S. implantable medical devices market have been working at breakneck speeds to help healthcare facilities maintain optimum devices inventory during COVID-19 pandemic. The unprecedented new wave in China and the U.K. has exposed the vulnerability of healthcare systems in these regions. Nevertheless, healthcare facilities in the U.S. are increasing efforts to be better prepared for potential outbreaks in other regions of the world.

Orthopedic, diabetic, and cardiovascular patients with high comorbidities are becoming key focus points for the U.S. implantable medical device manufacturers. Manufacturers are taking advantage of government stimulus packages to keep economies flowing during the pandemic.

Preference for Less Invasive Drug Delivery Devices by Medical Professionals

Robust innovations in vascular stents, from the preservation of blood flow to advancements made in electrostimulation devices that regulate heart rhythm, all are contributing to the growth of the U.S. implantable medical devices market. However, there is a need for less invasive devices, which modulate drug infusion safely and precisely. In many cases, it has been found that implantable drug delivery devices cause disruptions in concurrent treatments. Hence, companies in the U.S. implantable medical devices market are increasing efforts to design products that facilitate safe and comfortable administration of drugs. They are developing devices that meet the convenience of medical professionals and their patients.

Compatibility with diagnostic and therapeutic procedures is being preferred by medical professionals. Patients who use implantable drug delivery devices are usually undergoing concurrent medical attention for underlying conditions.

Sophisticated Implantable Medical Devices Hold Potentials to Lower Healthcare Costs and Complications

The U.S. implantable medical devices market is predicted to grow, owing to rise in chronic illnesses and improvements in active implanted medical devices. However, the industry is expected to be hampered by increased demand for non-invasive treatments, difficulties with implanted devices, and high cost of devices. Hence, companies in the U.S. implantable medical devices market are investing in R&D to employ design innovations in devices to lower overall healthcare costs and complications related to implanted devices.

Single-chamber, biventricular pacemakers, and dual-chamber are three main types of implanted pacemakers. The segment’s rise can be ascribed to factors including less post-surgical problems and existence of several leads to ensure normal cardiac physiology. In addition, investments to create technologically sophisticated products, along with wider applications of neuro-stimulators are likely to drive sales in the U.S. implantable medical devices market. Besides, attractive reimbursement programs for ENT surgeries in the U.S. is expected to boost market growth.

High Cost of Implantable Devices: Key Restraint

• Advanced implantable devices are costlier. Especially in case of cardiac implants, the price of such products goes on an upward curve with the increase in technical sophistication of the device. With the Affordable Care Act of 2010, also called as “Obamacare”, coming into effect from 2013, it is estimated that the medical devices industry will probably be one of the highest tax paying sectors in the U.S.
• This could adversely affect the prices of the implantable devices with the patients having to shell out extra money for implantation procedures. This is likely to hamper the demand for implantable devices, especially the technically advanced products.

Some of the prominent players in the U.S. Implantable Medical Devices market include:

• Abbott Laboratories
• Alcon Laboratories
• Biomet Incorporated
• Bausch and Lomb Incorporated
• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic Incorporated
• St. Jude Medical Incorporated
• Smith and Nephew plc
• Stryker Corporation
• Synthes Incorporated
• Zimmer Holdings Incorporated

Segments Covered in the Report

This report forecasts revenue growth at regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018-2030. For this study, Nova one advisor has segmented U.S. Implantable Medical Devices market based on services and region:

• Product Type
• Orthopedic Implants
• Reconstructive Joint Replacement
• Spinal Implants
• Cardiovascular Implants
• Dental Implants
• Intraocular Lens
• Breast Implants
• Other Implants
• Procedure
• Orthopedic Procedures
• Cardiovascular Procedures
• Other Procedures

Key Points Covered in U.S. Implantable Medical Devices Market Study:

• Growth of U.S. Implantable Medical Devices in 2022
• Market Estimates and Forecasts (2017-2030)
• Brand Share and Market Share Analysis
• Key Drivers and Restraints Shaping Market Growth
• Segment-wise
• Competition Mapping and Benchmarking
• Recommendation on Key Winning Strategies
• COVID-19 Impact on Demand for U.S. Implantable Medical Devices and How to Navigate
• Key Product Innovations and Regulatory Climate
• U.S. Implantable Medical Devices Consumption Analysis
• U.S. Implantable Medical Devices Production Analysis
• U.S. Implantable Medical Devices and Management